autolog bone marrow transplant high-risk remiss t-lineag acut lymphoblast leukemia immunotoxin marrow purg fourteen patient high-risk t-lineag acut lymphoblast leukemia complet remiss underw autolog bone marrow transplant bmt attempt residu diseas burden combin immunochemotherapi protocol cocktail immunotoxin t-lineag differenti antigen combin vitro activ cyclophosphamid congen autograft high dose pretranspl radiochemotherapi effect purg autograft patient median month rang month post bmt patient aliv diseas free month bmt novel quantit minim residu diseas mrd detect assay fluoresc multiparamet flow cytometri cell leukem progenitor cell lpc remiss bone marrow BM t-lineag all patient presenc residu lpc high number residu lpc remiss BM bmt poor prognost indic first evid biolog signific clinic valu vitro t-lineag all lpc assay median valu residu leukemia burden bmt mononuclear cell mnc lpc patient residu leukemia burden median valu outlook free relaps autolog bmt patient leukemia burden mantel-cox comparison log efficaci purg number lpc purg autograft estim number reinfus lpc probabl disease-fre surviv df result primari reason recurr leukemia ineffici pretranspl radiochemotherapi ineffici purg autograft 